| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $124.64M | $111.63M | $108.64M | $82.39M | $65.36M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $33.73M | $19.17M | $15.05M | $18.73M | $11.11M |
| Operating Income | – | – | – | – | – |
| Interest Expense | $179.51M | $182.76M | $129.28M | $50.15M | $29.33M |
| Tax Expense | $13.04M | $15.04M | $15.48M | $9.89M | $8.41M |
| Net Income | $28.46M | $39.75M | $42.16M | $22.66M | $22.38M |
| EPS (basic) | 0.9000 | 1.4900 | 1.5700 | 0.7900 | 0.9600 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |